セラテクノロジーズ インクに関するコメント

$セラテクノロジーズ インク(THTX.US)$
NEWS
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
Theratechnologies announced promising Phase 1 data for its investigational drug, sudocetaxel zendusortide, at the 2024 ASCO annual meeting.
The drug showed long-term disease stabilization in patients with solid tumors, lasting up to 45 weeks even after treatment ceased.
The study highlighted a uni...

$セラテクノロジーズ インク(THTX.US)$
NEWS
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
05/02/2024 - 04:30 AM
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors
Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the...

$セラテクノロジーズ インク(THTX.US)$ NASDAQ: THTX) announced moving to the next dose level in Part 3 of its Phase 1 clinical trial of sudocetaxel zendusortide in patients with advanced ovarian cancer.

📌Last week’s PDUFAs:
$ヘロン セラピューティクス(HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$リキディア テクノロジーズ(LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$セラテクノロジーズ インク(THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$サノフィ(SNY.US)$ & $リジェネロン ファーマシューティカルズ(REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...

$セラテクノロジーズ インク(THTX.US)$ Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA
4 MINUTES AGO, 7:00 AM EST

$セラテクノロジーズ インク(THTX.US)$ No new SEC filings except for yesterday’s FDA needs to review more? Could the FDA have come to a answer overnight? could it be a buyout? maybe a partner? hehehe! i love speculating! hehehe

$セラテクノロジーズ インク(THTX.US)$ Eyes on hard for what it could be now?

$セラテクノロジーズ インク(THTX.US)$ •FDA continues to review the file past the Prescription Drug User Fee Act goal date of January 22, 2024
MONTREAL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received correspondence from the U.S. Food and Drug Administration (FDA) regarding the Company's supplemental Biolo...

$セラテクノロジーズ インク(THTX.US)$ So i just checked and its still listed for a answer today 1/22/24 on the approval of sBLA

$セラテクノロジーズ インク(THTX.US)$ This is on the FDA PDUFA calendar for Monday 1/22/24